Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
762.950.17%
QQQ
722.780.18%
BTC/USD
81238.116.404%
DIA
516.000.02%
GLD
401.340.04%
TLT
81.320.08%

SELLAS Life Sciences Group Inc (SLS) Stock Price, Quote, News & History

SLSNASDAQ
Trade with Public
Trade with Public
$11.49
-0.04-0.35%
At close: Sep 18, 5:00 PM EST
$11.53
0.040.35%
After Hours: 6:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

SELLAS Life Sciences Gr (SLS) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$11.60
Close
$11.49
Volume / Avg.
14.58M / 8.38M
Day Range
$11.06 - $11.78
52 Wk Range
1.39 - 15.88
Market Cap
$2.33B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
28.8%
Days to Cover
6.88

Recent Sellas Life Sciences Group Inc News

SLS Stock Looks Like a $3 Billion Biotech Winner—This Short Seller Says the Market Has It Dangerously Wrong: 'Most Expensive Coin Flip' (UPDATED)

Short seller BMF Capital disclosed a short position in SELLAS Life Sciences, arguing the market has 'dangerously overvalued' the biotech.
Radhika Anilkumar Nadig

Benzinga Bulls and Bears: Nvidia, CrowdStrike, Intuit

Benzinga examined the prospects for many investors’ favorite stocks over the last week — here’s a look at some of our top stories.
Benzinga Senior Editor

When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock Surges

SELLAS stock gains momentum following FDA approval for Revolution Medicines, highlighting SLS009 preclinical pancreatic cancer data.
Vandana Singh

ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On Friday

US stocks lower, Nasdaq falls 400 pts. ManpowerGroup shares rise after upbeat earnings. Other big gainers: PHOE, SG, TRVI, DCBO, ZNTL, GPRE, SLS, FEIM, TRV, BHVN, KOS, BJRI, MBX.
Avi Kapoor

SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance Wall

SELLAS Life Sciences Group shares are trading lower Wednesday as investors take profits, with risk appetite softer across equities.
Henry Khederian

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-28.42M
Investing Cash Flow (TTM)
-
Financing Cash Flow (TTM)
141.47M
Free Cash Flow (TTM)
-28.42M
Capital Expenditure (TTM)
-
Net Change in Cash (TTM)
113.05M

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.19B
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
16.91
Earnings Yield % (TTM)
-1.91%
Earnings Yield % (FWD)
-0.82%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.68

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$138.34M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$11.60
Close
$11.49
Volume / Avg.
14.58M / 8.38M
Day Range
$11.06 - $11.78
52 Wk Range
1.39 - 15.88
Market Cap
$2.33B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
42
Short Interest
28.8%
Days to Cover
6.88

About

Sector
Health Care
Industry
Biotechnology
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a p...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy SELLAS Life Sciences Gr (SLS) stock?

A

You can purchase shares of SELLAS Life Sciences Gr (NASDAQ:SLS) through any online brokerage.

View our list of the best stock brokerages

Q

Who are SELLAS Life Sciences Gr (SLS) competitors?

Q

What is the forecast, or price target, for SELLAS Life Sciences Gr (SLS) stock?

A

SELLAS Life Sciences Gr has a consensus price target of $6.50.

Q

What is the current price for SELLAS Life Sciences Gr (SLS)?

A

The stock price for SELLAS Life Sciences Gr (NASDAQ: SLS) is $11.53 last updated September 18, 2026 at 6:00 PM EDT.

Q

Does SELLAS Life Sciences Gr (SLS) pay a dividend?

A

There are no upcoming dividends for SELLAS Life Sciences Gr.

Q

When is SELLAS Life Sciences Gr (NASDAQ:SLS) reporting earnings?

A

SELLAS Life Sciences Gr does not have any upcoming earnings scheduled.

Q

Is SELLAS Life Sciences Gr (SLS) going to split?

A

There is no upcoming split for SELLAS Life Sciences Gr.

Q

What sector and industry does SELLAS Life Sciences Gr (SLS) operate in?

A

SELLAS Life Sciences Gr is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved